Suppr超能文献

共同祖先特异性离子通道变体易导致药物诱导的心律失常。

Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias.

机构信息

Department of Medicine (Y.W., T.Y., C.M.S., L.L.D., A.M.G., G.E.D.), Vanderbilt University Medical Center, Nashville, TN.

Vanderbilt Institute for Clinical and Translational Research (B.D.L., E.H.F.-E.), Vanderbilt University Medical Center, Nashville, TN.

出版信息

Circulation. 2022 Jan 25;145(4):299-308. doi: 10.1161/CIRCULATIONAHA.121.054883. Epub 2022 Jan 7.

Abstract

BACKGROUND

Multiple reports associate the cardiac sodium channel gene () variants S1103Y and R1193Q with type 3 congenital long QT syndrome and drug-induced long QT syndrome. These variants are too common in ancestral populations to be highly arrhythmogenic at baseline, however: S1103Y allele frequency is 8.1% in African Americans and R1193Q 6.1% in East Asians. R1193Q is known to increase late sodium current () in cardiomyocytes derived from induced pluripotent stem cells but the role of these variants in modulating repolarization remains poorly understood.

METHODS

We determined the effect of S1103Y on QT intervals among African-American participants in a large electronic health record. Using cardiomyocytes derived from induced pluripotent stem cells carrying naturally occurring or genome-edited variants, we studied action potential durations (APDs) at baseline and after challenge with the repolarizing potassium current () blocker dofetilide and and at baseline.

RESULTS

In 1479 African-American participants with no confounding medications or diagnoses of heart disease, QT intervals in S1103Y carriers was no different from that in noncarriers. Baseline APD was no different in cells expressing the Y allele (SY, YY cells) compared with isogenic cells with the reference allele (SS cells). However, was increased in SY and YY cells and the blocker GS967 shortened APD in SY/YY but not SS cells (<0.001). was increased almost 2-fold in SY/YY cells compared with SS cells (tail current: 0.66±0.1 versus 1.2±0.1 pA/pF; <0.001). Dofetilide challenge prolonged APD at much lower concentrations in SY (4.1 nmol/L [interquartile range, 1.5-9.3]; n=11) and YY (4.2 nmol/L [1.7-5.0]; n=5) than in SS cells (249 nmol/L [22.3-2905]; n=14; <0.001 and <0.01, respectively) and elicited afterdepolarizations in 8/16 SY/YY cells but only in 1/14 SS cells. R1193Q cells similarly displayed no difference in baseline APD but increased I and increased dofetilide sensitivity.

CONCLUSIONS

These common ancestry-specific variants do not affect baseline repolarization, despite generating increased . We propose that increased serves to maintain normal repolarization but increases the risk of manifest QT prolongation with block in variant carriers. Our findings emphasize the need for inclusion of diverse populations in the study of adverse drug reactions.

摘要

背景

多项报告将心脏钠离子通道基因()的 S1103Y 和 R1193Q 变异与 3 型先天性长 QT 综合征和药物诱导的长 QT 综合征相关联。这些变异在祖先群体中太常见了,因此在基线时不会具有高度致心律失常性:S1103Y 等位基因频率在非裔美国人中为 8.1%,在东亚人中为 6.1%。已知 R1193Q 会增加诱导多能干细胞衍生的心肌细胞中的晚期钠电流(),但这些变异在调节复极化方面的作用仍知之甚少。

方法

我们确定了 S1103Y 在大型电子健康记录中非洲裔美国参与者的 QT 间期中的作用。使用携带天然或基因组编辑变异的诱导多能干细胞衍生的心肌细胞,我们研究了在复极化钾电流()阻滞剂地尔硫䓬和 以及 存在时的动作电位持续时间(APD)。

结果

在 1479 名无混杂药物或心脏病诊断的非裔美国参与者中,S1103Y 携带者的 QT 间期与非携带者没有差异。与具有参考等位基因的同基因细胞(SS 细胞)相比,表达 Y 等位基因的细胞(SY、YY 细胞)的基础 APD 没有差异。然而,在 SY 和 YY 细胞中,I 和 阻滞剂 GS967 缩短了 APD(<0.001)。与 SS 细胞相比,SY/YY 细胞中的 I 增加了近 2 倍(尾电流:0.66±0.1 对 1.2±0.1 pA/pF;<0.001)。地尔硫䓬挑战以远低于 SS 细胞(4.1 nmol/L [四分位间距,1.5-9.3];n=11)和 YY 细胞(4.2 nmol/L [1.7-5.0];n=5)的浓度延长了 SY(<0.001 和 <0.01)和 YY 细胞的 APD,并且在 8/16 的 SY/YY 细胞中引发了后除极,但仅在 1/14 的 SS 细胞中引发。R1193Q 细胞的基础 APD 也没有差异,但 I 增加,对地尔硫䓬的敏感性增加。

结论

尽管产生了增加的 I,但这些常见的与祖先特异性相关的变异并不影响基础复极。我们提出,增加的 I 有助于维持正常复极,但会增加变异携带者中明显 QT 延长的风险。我们的研究结果强调了在研究药物不良反应时纳入不同人群的必要性。

相似文献

3
Selective inhibition of physiological late Na current stabilizes ventricular repolarization.选择性抑制生理晚期钠电流可稳定心室复极。
Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H236-H245. doi: 10.1152/ajpheart.00071.2017. Epub 2017 Sep 29.
6
Multiple mechanisms underlie increased cardiac late sodium current.多种机制导致心脏晚期钠电流增加。
Heart Rhythm. 2019 Jul;16(7):1091-1097. doi: 10.1016/j.hrthm.2019.01.018. Epub 2019 Jan 21.

引用本文的文献

5
Stem cell models of inherited arrhythmias.遗传性心律失常的干细胞模型。
Nat Cardiovasc Res. 2024 Apr;3(4):420-430. doi: 10.1038/s44161-024-00451-x. Epub 2024 Mar 21.
6
Genetics and Pharmacogenetics of Atrial Fibrillation: A Mechanistic Perspective.心房颤动的遗传学与药物遗传学:机制视角
JACC Basic Transl Sci. 2024 Feb 28;9(7):918-934. doi: 10.1016/j.jacbts.2023.12.006. eCollection 2024 Jul.
8
Cardiovascular precision medicine - A pharmacogenomic perspective.心血管精准医学——药物基因组学视角
Camb Prism Precis Med. 2023 Jun 29;1:e28. doi: 10.1017/pcm.2023.17. eCollection 2023.

本文引用的文献

1
High-Throughput Reclassification of SCN5A Variants.高通量 SCN5A 变异体再分类。
Am J Hum Genet. 2020 Jul 2;107(1):111-123. doi: 10.1016/j.ajhg.2020.05.015. Epub 2020 Jun 12.
6
Pharmacogenomics.药物基因组学。
Lancet. 2019 Aug 10;394(10197):521-532. doi: 10.1016/S0140-6736(19)31276-0. Epub 2019 Aug 5.
8
Multiple mechanisms underlie increased cardiac late sodium current.多种机制导致心脏晚期钠电流增加。
Heart Rhythm. 2019 Jul;16(7):1091-1097. doi: 10.1016/j.hrthm.2019.01.018. Epub 2019 Jan 21.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验